These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35853234)

  • 1. Rebleeding in peptic ulcer bleeding - a nationwide cohort study of 19,537 patients.
    Laursen SB; Stanley AJ; Laine L; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 2022 Dec; 57(12):1423-1429. PubMed ID: 35853234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and prognosis in peptic ulcer bleeding.
    Laursen SB
    Dan Med J; 2014 Jan; 61(1):B4797. PubMed ID: 24547604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of scheduled second-look endoscopy on peptic ulcer bleeding: a prospective randomized multicenter trial.
    Park SJ; Park H; Lee YC; Choi CH; Jeon TJ; Park JC; Kim JH; Youn YH; Kim YJ; Kim JH; Lee KJ; Lim SG; Kim H; Bang BW
    Gastrointest Endosc; 2018 Feb; 87(2):457-465. PubMed ID: 28735835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer.
    García-Iglesias P; Villoria A; Suarez D; Brullet E; Gallach M; Feu F; Gisbert JP; Barkun A; Calvet X
    Aliment Pharmacol Ther; 2011 Oct; 34(8):888-900. PubMed ID: 21899582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of peptic ulcer rebleeding after scheduled second endoscopy: clinical or endoscopic factors?
    Chiu PW; Joeng HK; Choi CL; Kwong KH; Ng EK; Lam SH
    Endoscopy; 2006 Jul; 38(7):726-9. PubMed ID: 16810597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a model to predict rebleeding within three days after endoscopic hemostasis for high-risk peptic ulcer bleeding.
    Lai Y; Xu Y; Zhu Z; Pan X; Long S; Liao W; Li B; Zhu Y; Chen Y; Shu X
    BMC Gastroenterol; 2022 Feb; 22(1):64. PubMed ID: 35164682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Higher Dose Steroids Increases the Risk of Rebleeding After Endoscopic Hemostasis for Peptic Ulcer Bleeding.
    Kondo Y; Hatta W; Koike T; Takahashi Y; Saito M; Kanno T; Asanuma K; Asano N; Imatani A; Masamune A
    Dig Dis Sci; 2018 Nov; 63(11):3033-3040. PubMed ID: 30022453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for predicting rebleeding after initial endoscopic epinephrine injection monotherapy hemostasis in patients with peptic ulcer bleeding: a retrospective cohort study.
    He S; Liu L; Ouyang L; Wang J; Lv N; Chen Y; Shu X; Zhu Z
    BMC Gastroenterol; 2022 Jul; 22(1):368. PubMed ID: 35909111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of selective serotonin receptor inhibitors (SSRIs) is not associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in peptic ulcer bleeding.
    Laursen SB; Leontiadis GI; Stanley AJ; Hallas J; Schaffalitzky de Muckadell OB
    Aliment Pharmacol Ther; 2017 Aug; 46(3):355-363. PubMed ID: 28543334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: a systematic review.
    El Ouali S; Barkun A; Martel M; Maggio D
    Can J Gastroenterol Hepatol; 2014 Nov; 28(10):543-8. PubMed ID: 25390616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Dysfunction is an Independent Risk Factor for Rebleeding After Endoscopic Hemostasis in Patients with Peptic Ulcer Bleeding.
    Ogiyama H; Tsutsui S; Murayama Y; Matsushima K; Maeda S; Satake S; Seto K; Horiki M; Sanomura T; Imanaka K; Iishi H
    Turk J Gastroenterol; 2021 Aug; 32(8):622-630. PubMed ID: 34528875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for rebleeding and mortality following prophylactic transarterial embolization for patients with high-risk peptic ulcer bleeding: a single-center retrospective cohort study.
    Zetner D; Rasmussen IR; Frykman CP; Jensen LR; Jensen RJ; Possfelt-Møller E; Taudorf M; Penninga L
    Surg Endosc; 2024 Apr; 38(4):2010-2018. PubMed ID: 38413471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic Versus Conservative Therapy for Bleeding Peptic Ulcer with Adherent Clot: A Comprehensive Systematic Review and Meta-Analysis.
    Beran A; Al-Abboodi Y; Majzoub AM; Ghazaleh S; Sayeh W; Mohamed MFH; Elfert K; Mhanna M; Montalvan-Sanchez E; Musallam R; Jaber F; Bhatti U; Abdeljawad K; Al-Haddad M
    Dig Dis Sci; 2023 Oct; 68(10):3921-3934. PubMed ID: 37634184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C
    Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.
    Messmann H; Schaller P; Andus T; Lock G; Vogt W; Gross V; Zirngibl H; Wiedmann KH; Lingenfelser T; Bauch K; Leser HG; Schölmerich J; Holstege A
    Endoscopy; 1998 Sep; 30(7):583-9. PubMed ID: 9826134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) Study.
    Kim JS; Kim BW; Park SM; Shim KN; Jeon SW; Kim SW; Lee YC; Moon HS; Lee SH; Jung WT; Kim JI; Kim KO; Park JJ; Chung WC; Kim JH; Baik GH; Oh JH; Kim SM; Kim HS; Yang CH; Jung JT; Lim CH; Song HJ; Kim YS; Kim GH; Kim JH; Chung JI; Lee JH; Choi MH; Choi JK
    Gut Liver; 2018 May; 12(3):271-277. PubMed ID: 29409302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and outcome of gastrointestinal bleeding due to peptic ulcers and erosions - (BLUE study).
    Romstad KK; Detlie TE; Søberg T; Thomas O; Ricanek P; Jahnsen ME; Lerang F; Jahnsen J
    Scand J Gastroenterol; 2022 Jan; 57(1):8-15. PubMed ID: 34663154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers.
    Elmunzer BJ; Young SD; Inadomi JM; Schoenfeld P; Laine L
    Am J Gastroenterol; 2008 Oct; 103(10):2625-32; quiz 2633. PubMed ID: 18684171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease.
    Kuo MT; Yang SC; Lu LS; Hsu CN; Kuo YH; Kuo CH; Liang CM; Kuo CM; Wu CK; Tai WC; Chuah SK
    BMC Gastroenterol; 2015 May; 15():61. PubMed ID: 26268474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study.
    Liang CM; Hsu CN; Tai WC; Yang SC; Wu CK; Shih CW; Ku MK; Yuan LT; Wang JW; Tseng KL; Sun WC; Hung TH; Nguang SH; Hsu PI; Wu DC; Chuah SK;
    Medicine (Baltimore); 2016 Sep; 95(36):e4795. PubMed ID: 27603387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.